A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Clinical trial NCT01830400 · COMPLETED

Trial details

NCT number: NCT01830400
Sponsor: Eisai Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Partial Onset Seizures

Start date: 2012-04-01
Primary completion: 2014-03-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.